Ovarian reserve test: An impartial means to resolve the mismatch between chronological and biological age in the assessment of female reproductive chances

Reproductive Sciences

Volumn 21, Issue 5, 2014, Pages 632-639

  Gizzo, Salvatore ^a   Andrisani, Alessandra ^a   Esposito, Federica ^a   Oliva, Alessandra ^a   Zicchina, Cecilia ^a   Capuzzo, Denise ^a   Gangemi, Michele ^a   Nardelli, Giovanni Battista ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

assisted reproduction techniques; biological ovarian age; chronological ovarian age; embryo quality; pregnancy rate

Indexed keywords

CETRORELIX; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN;

ADULT; AGE; ARTICLE; COHORT ANALYSIS; EMBRYO (ANATOMY); EMBRYO TRANSFER; ENDOMETRIAL THICKNESS; ENDOMETRIUM; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; METAPHASE; OBSERVATIONAL STUDY; OOCYTE RETRIEVAL; OVARIAN FUNCTION TEST; OVARIAN RESERVE; OVARY FOLLICLE; PREDICTIVE VALUE; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; QUALITY CONTROL; RETROSPECTIVE STUDY; ULTRASOUND SCANNER; AGING; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; REPRODUCTION; STANDARDS;

ADULT; AGE FACTORS; AGING; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; OOCYTE RETRIEVAL; OVARIAN FUNCTION TESTS; OVARIAN RESERVE; PREGNANCY; REPRODUCTION; RETROSPECTIVE STUDIES;

EID: 84898981192     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113508821     Document Type: Article

References (23)

1. Qiao J, Wang ZB, Feng HL, et al Mol Aspects Med. 2013 :
2. isposizioni in materia di attività di Procreazione Medicalmente Assistita (Pma), Venezia, Italy, venerdì 8 luglio 2011 Anno XLII, N. 49.
3. Gizzo S, Ancona E, Patrelli TS, et al. Fertility preservation in young women with cervical cancer: an oncologic dilemma or a new conception of fertility sparing surgery?. Cancer Invest. 2013 ; 31 (3). 189
4. te Velde ER, Pearson PL. The variability of female reproductive aging. Hum Reprod Update. 2002 ; 8 (2). 141-154
5. Toner JP, Seifer DB. Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using anti-Müllerian hormone. Fertil Steril. 2013 ; 99 (7). 1825-1830
6. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2012 ; 98 (6). 1407-1415
7. Kwok R, Johnson NP. Ovarian biopsy has no role as a routine diagnostic test of ovarian reserve: a systematic review. Reprod Biomed Online. 2012 ; 24 (5). 492-495
8. Moolenaar LM, Broekmans FJ, van Disseldorp J, et al. Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic model. Fertil Steril. 2011 ; 96 (4). 889-894
9. La Marca A, Argento C, Sighinolfi G, et al. Possibilities and limits of ovarian reserve testing in ART. Curr Pharm Biotechnol. 2012 ; 13 (3). 398-408
10. Patrelli TS, Gizzo S, Sianesi N, et al. Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles?. PLoS One. 2012 ; 7 (9). e44571
11. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. Cambridge, UK: Cambridge University Press ; 1999 :
12. Son WY, Chung JT, Henderson S, et al Fertil Steril. 2013 :
13. Khoudja R, Li T, Ding C, et al. Effect of co-incubation of oocytes with a decreasing number of spermatozoa on embryo quality. Reprod Biomed Online. 2013 ; 26 (4). 353-359
14. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006 ; 12 (6). 685-718
15. De Brucker M, Camus M, Haentjens P, Verheyen G, Collins J, Tournaye H. Assisted reproduction using donor spermatozoa in women aged 40 and above: the high road or the low road?. Reprod Biomed Online. 2013 ; 26 (6). 577-585
16. Hourvitz A, Machtinger R, Maman E, Baum M, Dor J, Levron J. Assisted reproduction in women over 40 years of age: how old is too old?. Reprod Biomed Online. 2009 ; 19 (4). 599-603
17. Keehn J, Holwell E, Abdul-Karim R, et al. Recruiting egg donors online: an analysis of in vitro fertilization clinic and agency websites' adherence to American society for reproductive medicine guidelines. Fertil Steril. 2012 ; 98 (4). 995-1000
18. Akande VA, Fleming CF, Hunt LP, Keay SD, Jenkins JM. Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment. Hum Reprod. 2002 ; 17 (8). 2003-2008
19. Alviggi C, Humaidan P, Howles CM, Tredway D, Hillier SG. Biological versus chronological ovarian age: implications for assisted reproductive technology. Reprod Biol Endocrinol. 2009 ; 7: 101
20. Zhao J, Zhang Q, Li Y. The effect of endometrial thickness and pattern measured by ultrasonography on pregnancy outcomes during IVF-ET cycles. Reprod Biol Endocrinol. 2012 ; 10: 100
21. Zhang X, Chen CH, Confino E, Barnes R, Milad M, Kazer RR. Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization-embryo transfer. Fertil Steril. 2005 ; 83 (2). 336-340
22. Kondapalli LA, Molinaro TA, Sammel MD, Dokras A. A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles. Hum Reprod. 2012 ; 27 (9). 2690-2697
23. Chen CH, Zhang X, Barnes R, et al. Relationship between peak serum estradiol levels and treatment outcome in in vitro fertilization cycles after embryo transfer on day 3 or day 5. Fertil Steril. 2003 ; 80 (1). 75-79